Clinical TrialsSearch results
Number of results: 553
Other
- Phase II study of gemcitabine alone in locally advanced pancreatic cancer: Japan Clinical Oncology Group Study (JCOG 0506)
- pancreatic neoplasm
- Japan Clinical Oncology Group(JCOG)
- 2006-01-19
Other
- Phase II study of FOLFIRI plus Bevacitumab in the treatment of Japanese patients with advanced colorectal cancer.
- Colorectal cancer
- Japan Clinical Cancer Research Organization
- 2008-10-20
Other
- Phase II study of exemestane with doxorubicin plus paclitaxel (AP) followed by weekly paclitaxel (wP) as primary systemic chemotherapy for hormone-sensitive and HER2-negative postmenopausal breast cancer (SBCCSG-13 EAPAC)
- Postmenopausal breast cancer
- Saitama Breast Cancer Clinical Study Group (SBCCSG)
- 2008-08-05
Other
- Phase II study of combination chemotherapy and high-dose chemotherapy in treating young children with newly diagnosed medulloblastoma or supratentorial primitive neuroectodermal tumors
- medulloblastoma or supratentorial primitive neuroectodermal tumors
- Japanese Pediatric Brain Tumor Consortium
- 2006-12-08
Other
- Phase II study of Chemotherapy for Advanced or Recurrent Thymoma
- Thymoma (excluding thymic carcinoma)
- Japanese Association for Research on the Thymus
- 2006-04-01
Other
- Phase II Study of bi-weekly Paclitaxel (TAXOL)for fluorouracil resistant advanced and recurrent Gastric Cancer
- 5-fluorouracil resistant advanced and recurrent Gastric Cancer
- The Tokyo Cooperative Oncology Group
- 2005-11-18
Other
- Phase II study of amrubicin combined with carboplatin for unresectable invasive thymoma or thymic carcinoma
- Thymoma/Thymic carcinoma
- Tohoku University Hospital
- 2010-03-31
Other
- Phase II study of amrubicin combined with carboplatin for refractory relapsed small-cell lung cancer
- Small-cell lung cancer
- Tohoku University Hospital
- 2010-03-31
Other
- Phase II study of 4-drug combination chemotherapy in patients with non-small cell lung cancer harboring EGFR active mutation.
- Non-small cell lung cancer
- Kurata Takayasu
- 2019-02-25
Other
- Phase II prospective treatment study for IgG4+MOLPS
- IgG4+MOLPS (IgG4+Multiorgan lymphoproliferative syndrome)
- Department of Hematology and Immunology, Kanazawa Medical University
- 2009-08-10